These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 32271370)
21. Expression of palladin is associated with disease progression in metastatic high-grade serous carcinoma. Davidson B; Bock AJ; Holth A; Nymoen DA Cytopathology; 2020 Nov; 31(6):572-578. PubMed ID: 32741023 [TBL] [Abstract][Full Text] [Related]
22. Improving the cytological diagnosis of high-grade serous carcinoma in ascites with a panel of complementary biomarkers in cell blocks. Zhang X; Chen L; Liu Y; Xu Y; Zhang X; Shi Y; Wang C; Zhang PL; Liu Y Cytopathology; 2018 Jun; 29(3):247-253. PubMed ID: 29280203 [TBL] [Abstract][Full Text] [Related]
23. [Diagnosis of hematolymphoid malignancy by using effusion fluid cytology specimens: a study of 33 cases]. Su XY; Xu X; Tang Y; Li GD Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):542-6. PubMed ID: 20021966 [TBL] [Abstract][Full Text] [Related]
24. The strength of cytomorphology and efficacy of immuno-cytochemistry in distinguishing hepatocellular carcinoma from its mimics on fine-needle aspiration cytology. Chikhale M; Toi PC; Siddaraju N; Ananthakrishnan R Diagn Cytopathol; 2021 Jul; 49(7):864-875. PubMed ID: 33929782 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemistry on cell blocks for diagnosis of malignancy in abdomino-pelvic lesions and ascitic fluid cytology at a rural cancer center: A paradigm shift in cancer management. Bansal S; Sancheti S; Sali AP; Somal PK; Gulia A; Kapoor R J Cancer Res Ther; 2022 Dec; 18(Supplement):S410-S419. PubMed ID: 36510996 [TBL] [Abstract][Full Text] [Related]
27. Role of Fine Needle Aspiration Cytology in the Diagnosis of Gynecologic Tumors. Goyal A Acta Cytol; 2023; 67(2):195-212. PubMed ID: 36917955 [TBL] [Abstract][Full Text] [Related]
28. [Evaluation of immunohistochemistry staining and cytologic diagnosis by using cell block sections prepared with effusion fluid cytology specimens]. Mao YY; Yang M; Liu DG; Lin MH; Zhang LQ; Chen ZQ Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):547-50. PubMed ID: 20021967 [TBL] [Abstract][Full Text] [Related]
29. Carcinosarcoma arising from high-grade serous carcinoma of the ovary without estrogen receptor, WT-1, and PAX8 immunoreactivity. Harada N; Nobuhara I; Haruta N; Higashiura Y; Fujii H; Yamao K; Shimada K Taiwan J Obstet Gynecol; 2022 Jan; 61(1):110-114. PubMed ID: 35181017 [TBL] [Abstract][Full Text] [Related]
30. SOX17 is a highly sensitive and specific marker for metastatic ovarian and endometrial carcinomas in cytology cell block specimens. Satturwar S; Shaker N; Sinclair W; Shen R; Parwani AV; Ding Q; Li Z Cancer Cytopathol; 2023 Jul; 131(7):465-470. PubMed ID: 37195085 [TBL] [Abstract][Full Text] [Related]
31. p53 immunohistochemistry for distinguishing reactive mesothelium from low grade ovarian carcinoma. Pindzola JA; Kovatich AJ; Bibbo M Acta Cytol; 2000; 44(1):31-6. PubMed ID: 10667156 [TBL] [Abstract][Full Text] [Related]
32. Lung adenocarcinoma and its thyroid metastasis characterized on fine-needle aspirates by cytomorphology, immunocytochemistry, and next-generation sequencing. Bellevicine C; Vigliar E; Malapelle U; Carelli E; Fiorelli A; Vicidomini G; Cappabianca S; Santini M; Troncone G Diagn Cytopathol; 2015 Jul; 43(7):585-9. PubMed ID: 25900221 [TBL] [Abstract][Full Text] [Related]
33. Solitary cutaneous metastasis from an ovarian high-grade serous carcinoma at the initial presentation: Cytologic diagnosis of a rare manifestation. Kaur A; Gupta P; Gupta N; Rai B Diagn Cytopathol; 2022 Mar; 50(3):E81-E85. PubMed ID: 34717023 [TBL] [Abstract][Full Text] [Related]
34. Is cell block technique useful to predict histological type in patients with ovarian mass and/or body cavity fluids? Maseki Z; Kajiyama H; Nishikawa E; Satake T; Misawa T; Kikkawa F Nagoya J Med Sci; 2020 May; 82(2):225-235. PubMed ID: 32581403 [TBL] [Abstract][Full Text] [Related]
35. Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma. Qiu C; Wang Y; Wang X; Zhang Q; Li Y; Xu Y; Jin C; Bu H; Zheng W; Yang X; Lu N; Kong B Int J Oncol; 2018 Jun; 52(6):2041-2050. PubMed ID: 29620196 [TBL] [Abstract][Full Text] [Related]
36. Cytological features of ovarian or tubal high-grade serous carcinoma: A retrospective study of 12 cases with abnormal cervical liquid-based smear. Xu Y; Liu B; Zhang X; Chen L Diagn Cytopathol; 2021 Nov; 49(11):1207-1212. PubMed ID: 34506642 [TBL] [Abstract][Full Text] [Related]
37. Cytology of peritoneal implants of borderline serous tumor of ovaries in ascitic fluid. Sharma S; Mohapatra DS; Gupta N; Srinivasan R; Rajwanshi A; Dey P Cytojournal; 2021; 18():17. PubMed ID: 34512788 [TBL] [Abstract][Full Text] [Related]
38. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma. Allard FD; Bell D; Stelow EB Cancer Cytopathol; 2018 Aug; 126(8):567-574. PubMed ID: 29797680 [TBL] [Abstract][Full Text] [Related]
39. Characteristics and prognostic significance of incidentally detected cancer cells in uterine specimens of patients with pelvic high-grade serous carcinoma. Ushigusa T; Yoshida H; Kuno I; Kojima N; Ishikawa M; Kato T Cytopathology; 2020 Mar; 31(2):122-129. PubMed ID: 31883401 [TBL] [Abstract][Full Text] [Related]
40. High-grade serous ovarian carcinoma with mucinous differentiation: report of a rare and unique case suggesting transition from the "SET" feature of high-grade serous carcinoma to the "STEM" feature. Hatano Y; Tamada M; Asano N; Hayasaki Y; Tomita H; Morishige KI; Hara A Diagn Pathol; 2019 Jan; 14(1):4. PubMed ID: 30636633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]